Rankings
▼
Calendar
EYPT Q2 2018 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$715,000
+2.0% YoY
Gross Profit
-$4M
-566.4% margin
Operating Income
-$10M
-1368.1% margin
Net Income
-$34M
-4815.1% margin
EPS (Diluted)
$-6.22
QoQ Revenue Growth
-23.0%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$974,000
Balance Sheet
Total Assets
$72M
Total Liabilities
$60M
Stockholders' Equity
$12M
Cash & Equivalents
$39M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$715,000
$701,000
+2.0%
Gross Profit
-$4M
$701,000
-677.7%
Operating Income
-$10M
-$6M
-59.4%
Net Income
-$34M
-$6M
-462.9%
← FY 2018
All Quarters
Q3 2018 →